These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Chen L; Mai W; Chen M; Hu J; Zhuo Z; Lei X; Deng L; Liu J; Yao N; Huang M; Peng Y; Ye W; Zhang D Pharmacol Res; 2017 Sep; 123():130-142. PubMed ID: 28712972 [TBL] [Abstract][Full Text] [Related]
4. Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover. Gao F; Alwhaibi A; Artham S; Verma A; Somanath PR Br J Cancer; 2018 May; 118(11):1464-1475. PubMed ID: 29755115 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells. Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862 [TBL] [Abstract][Full Text] [Related]
6. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062 [TBL] [Abstract][Full Text] [Related]
7. Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis. Alwhaibi A; Verma A; Artham S; Adil MS; Somanath PR Biochem Pharmacol; 2019 Oct; 168():1-13. PubMed ID: 31202735 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Jin Y; Cui Z; Li X; Jin X; Peng J Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533 [TBL] [Abstract][Full Text] [Related]
10. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179. Jo E; Park SJ; Choi YS; Jeon WK; Kim BC Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431 [TBL] [Abstract][Full Text] [Related]
11. Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer. Cordonnier T; Bishop JL; Shiota M; Nip KM; Thaper D; Vahid S; Heroux D; Gleave M; Zoubeidi A Int J Cancer; 2015 Mar; 136(6):E496-507. PubMed ID: 25130271 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression. Sabbineni H; Verma A; Artham S; Anderson D; Amaka O; Liu F; Narayanan SP; Somanath PR Biochem Pharmacol; 2019 Jun; 164():205-215. PubMed ID: 30991049 [TBL] [Abstract][Full Text] [Related]
13. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells. Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138 [TBL] [Abstract][Full Text] [Related]
14. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition. Salomon A; Keramidas M; Maisin C; Thomas M Oncotarget; 2015 May; 6(13):11421-33. PubMed ID: 25823656 [TBL] [Abstract][Full Text] [Related]
15. Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer. Yang M; Liu H; Qiu GP; Gao F Med Oncol; 2021 Nov; 39(1):8. PubMed ID: 34761338 [TBL] [Abstract][Full Text] [Related]
16. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells. Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056 [TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency aggravates growth and metastasis of prostate cancer through promoting EMT in two β-catenin-related mechanisms. Zhang ZH; Liu MD; Yao K; Xu S; Yu DX; Xie DD; Xu DX J Nutr Biochem; 2023 Jan; 111():109177. PubMed ID: 36223833 [TBL] [Abstract][Full Text] [Related]
20. Hydrogen Sulfide Inhibits Transforming Growth Factor-β1-Induced EMT via Wnt/Catenin Pathway. Guo L; Peng W; Tao J; Lan Z; Hei H; Tian L; Pan W; Wang L; Zhang X PLoS One; 2016; 11(1):e0147018. PubMed ID: 26760502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]